27 results
8-K
EX-99.2
ORGO
Organogenesis Holdings Inc - Ordinary Shares
9 Aug 21
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
4:09pm
-term strategic growth objectives.”
“We are very pleased to expand our relationship with the Organogenesis team as they continue to drive innovation … companies and their investors move bold ideas forward, fast. SVB provides targeted financial services and expertise through its offices in innovation centers
424B4
ORGO
Organogenesis Holdings Inc - Ordinary Shares
16 Nov 20
Prospectus supplement with pricing info
4:57pm
and regenerative medicine in general, we believe we are well positioned to capture this opportunity.
Launch Robust Pipeline of Products and Drive Innovation … viability of a new product, technology, material or other innovation. In addition, even if we are able to successfully develop enhancements or new
424B5
35o75v
22 Nov 19
Prospectus supplement for primary offering
7:38pm
424B5
p3o5fy3 ne
19 Nov 19
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
n7qew05m
14 Mar 19
Organogenesis Holdings Inc. Announces New $100 Million Credit Agreement with Silicon Valley Bank and MidCap Financial
4:23pm
POS AM
dxorkq9l7b
11 Feb 19
Prospectus update (post-effective amendment)
8:50am
424B3
xxrv 6toe16
4 Feb 19
Prospectus supplement
8:11am
S-3/A
naejquy4 bukno34
10 Jan 19
Shelf registration (amended)
12:00am
S-3
nrqpp
24 Dec 18
Shelf registration
12:00am
8-K
EX-10.25
ib91yxjwqbcy896f y21
11 Dec 18
Report of Independent Registered Public Accounting Firm
5:14pm
424B3
kp0xc
30 Nov 18
Prospectus supplement
1:40pm